Table of Contents
1. INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2. RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3. MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4. MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL ARTIFICIAL PANCREAS MARKET, BY CONTROL TYPE
5.1 THRESHOLD SUSPEND DEVICE SYSTEM
5.2 NON-THRESHOLD SUSPEND DEVICE SYSTEM
5.3 CONTROL-TO-RANGE (CTR) SYSTEM
5.4 CONTROL-TO-TARGET (CTT) SYSTEM
6. GLOBAL ARTIFICIAL PANCREAS MARKET, BY TREATMENT TYPE
6.1 INSULIN ONLY
6.2 BI-HORMONAL
6.3 HYBRID
7. GLOBAL ARTIFICIAL PANCREAS MARKET, BY END USERS
7.1 HOSPITALS AND CLINICS
7.2 RESEARCH
7.3 OTHERS
8. GLOBAL ARTIFICIAL PANCREAS MARKET, BY REGION
8.1 NORTH AMERICA
8.1.1 INTRODUCTION
8.2 EUROPE
8.2.1 INTRODUCTION
8.3 ASIA-PACIFIC
8.3.1 INTRODUCTION
8.4 MIDDLE EAST & AFRICA
8.4.1 INTRODUCTION
9. COMPETITIVE LANDSCAPE
9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
9.1.1 STRATEGIC PARTNERSHIP
9.1.2 MERGER & ACQUISITION
10. COMPANY PROFILE
10.1 MEDTRONIC
10.1.1 OVERVIEW
10.1.2 PRODUCT OVERVIEW
10.1.3 FINANCIALS
10.1.4 KEY DEVELOPMENTS
10.2 JOHNSON & JOHNSON
10.2.1 OVERVIEW
10.2.2 PRODUCT OVERVIEW
10.2.3 FINANCIALS
10.2.4 KEY DEVELOPMENTS
10.3 BETA BIONICS
10.3.1 OVERVIEW
10.3.2 PRODUCT OVERVIEW
10.3.3 FINANCIALS
10.3.4 KEY DEVELOPMENT
10.4 BIGFOOT BIOMEDICAL
10.4.1 OVERVIEW
10.4.2 PRODUCT OVERVIEW
10.4.3 FINANCIALS
10.4.4 KEY DEVELOPMENTS
10.5 ADMETSYS (PIPELINE PRODUCT ANALYSIS)
10.5.1 OVERVIEW
10.5.2 PRODUCT OVERVIEW
10.5.3 FINANCIALS
10.5.4 KEY DEVELOPMENTS
10.6 ANIMAS CORPORATION
10.6.1 OVERVIEW
10.6.2 PRODUCT OVERVIEW
10.6.3 FINANCIALS
10.6.4 KEY DEVELOPMENTS
10.7 DEFYMED
10.7.1 OVERVIEW
10.7.2 PRODUCT OVERVIEW
10.7.3 FINANCIALS
10.7.4 KEY DEVELOPMENTS
10.8 DEXCOM
10.8.1 OVERVIEW
10.8.2 PRODUCT OVERVIEW
10.8.3 FINANCIALS
10.8.4 KEY DEVELOPMENTS
10.9 INSULET
10.9.1 OVERVIEW
10.9.2 PRODUCT OVERVIEW
10.9.3 FINANCIALS
10.9.4 KEY DEVELOPMENTS
10.10 SEMMA THERAPEUTICS
10.10.1 OVERVIEW
10.10.2 PRODUCT OVERVIEW
10.10.3 FINANCIALS
10.10.4 KEY DEVELOPMENTS
10.11 TYPEZERO TECHNOLOGIES
10.11.1 OVERVIEW
10.11.2 PRODUCT OVERVIEW
10.11.3 FINANCIALS
10.11.4 KEY DEVELOPMENTS
10.12 TANDEM DIABETES CARE
10.12.1 OVERVIEW
10.12.2 PRODUCT OVERVIEW
10.12.3 FINANCIALS
10.12.4 KEY DEVELOPMENTS
10.8 MEDTECH
10.13.1 OVERVIEW
10.13.2 PRODUCT OVERVIEW
10.13.3 FINANCIALS
10.13.4 KEY DEVELOPMENTS
10.14 OTHERS
CONCLUSION
11.1 KEY FINDINGS
11.1.1 FROM CEO’S VIEWPOINT
11.1.2 UNMET NEEDS OF THE MARKET
11.2 KEY COMPANIES TO WATCH
11.3 PREDICTION OF ARTIFICIAL PANCREAS INDUSTRY
12. APPENDIX
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
